Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2022-05-16
DOI
10.1080/14656566.2022.2076592
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
- (2022) Marc Miravitlles et al. International Journal of Chronic Obstructive Pulmonary Disease
- Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan
- (2021) Kai-Lin Chiu et al. Scientific Reports
- Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
- (2021) Jean Bourbeau et al. International Journal of Chronic Obstructive Pulmonary Disease
- Is Blood Eosinophil Count a Biomarker for Chronic Obstructive Pulmonary Disease in a Real-World Clinical Setting? Predictive Property and Longitudinal Stability in Japanese Patients
- (2021) Koichi Nishimura et al. Diagnostics
- Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
- (2021) Marc Miravitlles et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Adherence to Treatment Recommendations for Chronic Obstructive Pulmonary Disease - Results from the Swedish National Airway Register
- (2021) Kjell Larsson et al. International Journal of Chronic Obstructive Pulmonary Disease
- Inhaled corticosteroids and risk of lung cancer among chronic obstructive pulmonary disease patients: a comprehensive analysis of nine prospective cohorts
- (2021) Fan Ge et al. Translational Lung Cancer Research
- A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial
- (2021) Mona Bafadhel et al. EUROPEAN RESPIRATORY JOURNAL
- Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer
- (2021) Stefan Prekovic et al. Nature Communications
- Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials
- (2021) Hong Chen et al. Frontiers in Pharmacology
- GOLD 2021 Strategy Report: Implications for Asthma–COPD Overlap
- (2021) Miguel Roman-Rodriguez et al. International Journal of Chronic Obstructive Pulmonary Disease
- Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD
- (2021) Marc Miravitlles et al. European Respiratory Review
- Inhaled corticosteroids and risk of tuberculosis—How bad is the risk?
- (2021) Rajesh Venkitakrishnan et al. Indian Journal of Tuberculosis
- Early chronic obstructive pulmonary disease: A new perspective
- (2021) Huan-Huan Lu et al. Chronic Diseases and Translational Medicine
- Glucocorticoids Elevate Pseudomonas aeruginosa Binding to Airway Epithelium by Upregulating Syndecan-1 Expression
- (2021) Dong Liu et al. Frontiers in Microbiology
- Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
- (2021) Jae-Hwa Choi et al. International Journal of Chronic Obstructive Pulmonary Disease
- Discordant diagnostic criteria for pneumonia in COPD trials: a review
- (2021) Robert A. Wise et al. European Respiratory Review
- Inhaled Corticosteroids and the Lung Microbiome in COPD
- (2021) Holly R. Keir et al. Biomedicines
- Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection and Pneumonia Risk in Chronic Obstructive Pulmonary Disease: A Network Analysis
- (2020) Miguel Angel Martinez-Garcia et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD
- (2020) Alexander G. Mathioudakis et al. EUROPEAN RESPIRATORY JOURNAL
- Fixed Triple Therapy in COPD and Survival: Living Better, Longer, or Both?
- (2020) Jørgen Vestbo AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline
- (2020) Linda Nici et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease
- (2020) Mohamad Isam Saeed et al. DIABETES OBESITY & METABOLISM
- Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: A European Respiratory Society Guideline
- (2020) James D. Chalmers et al. EUROPEAN RESPIRATORY JOURNAL
- A case scenario study on adherence to COPD GOLD recommendations by general practitioners in a rural area of southern Italy: The “progetto PADRE”
- (2020) Mauro Maniscalco et al. RESPIRATORY MEDICINE
- Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short
- (2020) Claudio Tantucci et al. International Journal of Chronic Obstructive Pulmonary Disease
- Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study
- (2020) Chloe I Bloom et al. International Journal of Chronic Obstructive Pulmonary Disease
- Eosinophils in COPD—Current Concepts and Clinical Implications
- (2020) Katarzyna Mycroft et al. Journal of Allergy and Clinical Immunology-In Practice
- Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
- (2020) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endo-phenotyping of COPD patients
- (2020) Peter J. Barnes Expert Review of Respiratory Medicine
- Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
- (2020) Tsan-Ming Huang et al. BMC INFECTIOUS DISEASES
- Osteoporosis and fracture risk associated with ICS use among Swedish COPD patients: the ARCTIC study
- (2020) Christer Janson et al. EUROPEAN RESPIRATORY JOURNAL
- Benefits and Risks of Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease Classified by Blood Eosinophil Counts
- (2020) Zenya Saito et al. LUNG
- Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings
- (2020) Paola Rogliani et al. Expert Review of Clinical Pharmacology
- The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
- (2020) Jung-Ki Yoon et al. International Journal of Chronic Obstructive Pulmonary Disease
- Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice
- (2020) Lisette van den Bemt et al. npj Primary Care Respiratory Medicine
- Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients
- (2020) Björn Ställberg et al. npj Primary Care Respiratory Medicine
- Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies
- (2020) Luigino Calzetta et al. Expert Review of Respiratory Medicine
- Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for COPD: A Randomized, Double-Blind, Multi-Center Parallel-Group Study
- (2020) Fernando J. Martinez et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Glucocorticoid-induced osteoporosis: 2019 concise clinical review
- (2019) G. Adami et al. OSTEOPOROSIS INTERNATIONAL
- Stability of the Blood Eosinophilic Phenotype in Stable and Exacerbated COPD
- (2019) Desiree M. Schumann et al. CHEST
- Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): a population-based cohort study
- (2019) A.J.N. Raymakers et al. EUROPEAN RESPIRATORY JOURNAL
- Airway inflammation in COPD- progress to precision medicine
- (2019) Christopher Brightling et al. EUROPEAN RESPIRATORY JOURNAL
- Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers
- (2019) Mario Cazzola et al. Molecular Diagnosis & Therapy
- Inhaled corticosteroid use and the incidence of lung cancer in COPD
- (2019) Samy Suissa et al. EUROPEAN RESPIRATORY JOURNAL
- Overuse and Misuse of Inhaled Corticosteroids Among Veterans with COPD: a Cross-sectional Study Evaluating Targets for De-implementation
- (2019) Matthew F. Griffith et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients
- (2018) Marco Contoli et al. European Journal of Internal Medicine
- The reproducibility of COPD blood eosinophil counts
- (2018) Thomas Southworth et al. EUROPEAN RESPIRATORY JOURNAL
- Inhaled corticosteroids in COPD and the risk of lung cancer
- (2018) Yu min Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
- (2018) Alberto Papi et al. LANCET
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
- (2018) David A. Lipson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
- (2018) Mona Bafadhel et al. Lancet Respiratory Medicine
- Clinical Approach to the Therapy of Asthma-COPD Overlap
- (2018) Diego J. Maselli et al. CHEST
- Inhaled corticosteroid containing combinations and mortality in COPD
- (2018) Jørgen Vestbo et al. EUROPEAN RESPIRATORY JOURNAL
- Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
- (2018) Gary T Ferguson et al. Lancet Respiratory Medicine
- Inhaled corticosteroids in COPD: the final verdict is…
- (2018) Janice M. Leung et al. EUROPEAN RESPIRATORY JOURNAL
- What is Early COPD and Why is it Important?
- (2018) Joan B. Soriano et al. EUROPEAN RESPIRATORY JOURNAL
- Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD
- (2017) Ciro Casanova et al. EUROPEAN RESPIRATORY JOURNAL
- Triple therapy for symptomatic patients with COPD
- (2017) Leonardo M Fabbri et al. LANCET
- Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
- (2017) Jørgen Vestbo et al. LANCET
- The Challenges of Precision Medicine in COPD
- (2017) Mario Cazzola et al. Molecular Diagnosis & Therapy
- Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus
- (2017) Mario Cazzola et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable
- (2017) Marc Miravitlles et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
- (2017) Christer Janson et al. International Journal of Chronic Obstructive Pulmonary Disease
- Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial
- (2016) Jørgen Vestbo et al. LANCET
- Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
- (2016) Dave Singh et al. LANCET
- Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
- (2016) Jadwiga A. Wedzicha et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhaled corticosteroids can reduce osteoporosis in female patients with COPD
- (2016) Shih-Feng Liu et al. International Journal of Chronic Obstructive Pulmonary Disease
- Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis
- (2016) Ian D Pavord et al. Lancet Respiratory Medicine
- Inhaled corticosteroids: potency, dose equivalence and therapeutic index
- (2015) Peter T. Daley-Yates BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Eosinophilic inflammation in COPD: prevalence and clinical characteristics: Table 1–
- (2014) Dave Singh et al. EUROPEAN RESPIRATORY JOURNAL
- Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
- (2014) David Price et al. International Journal of Chronic Obstructive Pulmonary Disease
- Inhaled corticosteroids for chronic obstructive pulmonary disease
- (2013) Mario Cazzola et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Coexistence of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Prevalence and Risk Factors in Young, Middle-aged and Elderly People from the General Population
- (2013) Roberto de Marco et al. PLoS One
- Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice
- (2012) Marc Miravitlles et al. EUROPEAN RESPIRATORY JOURNAL
- Slaying the CVD dragon with steroids
- (2010) D. D. Sin et al. EUROPEAN RESPIRATORY JOURNAL
- Prevalence of Comorbidities in Patients with Chronic Obstructive Pulmonary Disease
- (2010) Mario Cazzola et al. RESPIRATION
- Heart failure, myocardial infarction, lung cancer and death in COPD patients: A UK primary care study
- (2010) Luis A. García Rodríguez et al. RESPIRATORY MEDICINE
- Cardiovascular events in patients with COPD: TORCH Study results
- (2010) P. M. A. Calverley et al. THORAX
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now